Search filters

List of works by Markus Axelsson

Cerebrospinal fluid NCAM levels are modulated by disease-modifying therapies

scientific article published on 05 March 2019

Cerebrospinal fluid biomarkers in patients with neurological symptoms but without neurological diseases

scientific article published on 31 May 2019

Cerebrospinal fluid growth-associated protein 43 in multiple sclerosis

scientific article published on 21 November 2019

Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism

scientific article published on 20 May 2019

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

scientific article published on 17 June 2019

Inflammation-related plasma and CSF biomarkers for multiple sclerosis

scientific article published on 26 May 2020

Intrathecal immunoreactivity in people with or without previous infectious mononucleosis

scientific article published on 16 May 2020

Leukoencephalopathia, demyelinating peripheral neuropathy and dural ectasia explained by a not formerly described de novo mutation in the SAMD9L gene, ends 27 years of investigations - a case report

scientific article published on 03 May 2019

Neuronal antibodies in adult patients with new-onset seizures: A prospective study

scientific article published on 06 October 2019

Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone

Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone

Paulina is supported by:

About Paulina

Help